Vorinostat Active Not Recruiting Phase 1 Trials for Liver Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01075113Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer